Ce lien vous redirigera vers un site Internet pour lequel notre politique de confidentialité ainsi que nos conditions générales ne sont pas appliquées. Nous vous recommandons de lire attentivement les règles de tout nouveau site que vous visitez.
Références
1. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D et al. (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37 (38): 2893-2962.
2. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 6 213-220.
3. Menke J, Luthje L, Kastrup A, Larsen J (2010) Thromboembolism in atrial fibrillation. Am J Cardiol 105 (4): 502-510.
4. Hillis AE, Tippett DC (2014) Stroke Recovery: Surprising Influences and Residual Consequences. Advances in Medicine 2014 1-10.
5. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG et al. (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. Bmj 354 i4482.
6. Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A et al. (2010) Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 29 (1): 43-49.
7. Andrew NE, Thrift AG, Cadilhac DA (2013) The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made? Neuroepidemiology 40 (4): 227-239.
8. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest. ;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.
9. Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J et al. (2018) Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. PLoS One 13 (1): e0191592.
10. Guide parcours de soin de la HAS –Fibrillation atriale (février 2014) 110338-190326
11. https://www.has-sante.fr/jcms/c_2851086/fr/les-anticoagulants-oraux.
12. https://www.ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Traitement-par-antivitamines-K-AVK-nouvelles-informations-Lettre-aux-professionnels-de-sante.